health-news

Single pill for cardio-vascular diseases tested

Chandigarh, Sep 5 : Doctors and researchers have come out with a single pill, called a polypill, to help patients with cardio-vascular diseases (CVD) to overcome the problem of taking too many medicines.


According to the latest issue of the Journal of American Medical Association, a study was conducted on CVD patients in India and three European countries.

The study, conducted between July 2010 and July 2011, showed 86.3 percent of people using polypill continued with it but only 64.7 percent of those who were on multiple medication went with the many-medicine theory.

The study was conducted with the help of 28 Indian health-related institutions, including the All India Institute of Medical Sciences and Post-Graduate Institute of Medical Education and Research. The European Commission funded the study and it was planned by London's Imperial College.

The polypill is a combination of aspirin, lipid-lowering drug simvastatin and blood pressure lowering agents.

The study showed adherence to multiple medications was as low as 10 percent among Indian patients.

However, researchers said in case the polypill showed any side-effects, it has to be discontinued.

--IANS (Posted on 05-09-2013)

health-news headlines

Period pain affects work of girls: Research

Yoga may be the answer to infertility

Weight loss surgery linked to appetite, taste change

'Vitamin supplements no substitute for natural foods'

How food texture affects our calorie intake

Cheap 'magic' polypill helps fight heart diseases

Extroverts make for happier humans across cultures

Low-calorie restaurant menus may be making us unhealthier

Why rice is good for your health

Pregnant women with high BP risk preterm delivery and low birth weight

Casual marijuana use could lead to brain abnormalities in young adults

Antibiotics improve growth in kids in developing countries

Quick Links: Goa | Munnar | Pondicherry | Free Yearly Horoscope '2014

Comments

Your e-mail:


Your Full Name:


Type verification image:
verification image, type it in the box

Message:

Back to Top